Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Mal5g4082 ATGCCTAAAAATCCATGGACCCTCTTCTTTTTATTCATTTTCCTTTTACTTCCACACCATTTTTTTCTATCTATTGCTGTTAACACACAAGGGGAAGCTCTTCTTTCATGGAAGAGAACCTTGAATGGATCCTTGGAGATATTGAATAACTGGGACCCAATTGAAGATACACCATGTAGCTGGTTTGGAGTGAGTTGCAACATGAAGAATGAAGTAGTACAATTGGATCTAAGGTATGTGGATTTGCTTGGAAAATTACCAACAAATTTCACCTCATTGTTCTCCTTGACCAGTCTTATCTTGACGGGAACGAATCTCACTGGTTCGATCCCGAAAGAAATAGCCAATCTTTTTGAACTCAGCTACTTGGACTTGAGTGACAATGCATTGAGCGGCGAAATCCCAAGTGAACTCTGCTACTTGCCTAAACTCGAGGAACTTCATCTGAACTCGAACGAGCTCGTGGGGTCGATACCAATCGCAGTTGGGAACCTCACAAAGTTAACAAAGCTGATCTTATATGACAATCAGCTGAGCGGCAAAATTCCGAACACAATTGGCAACATGAAGAATCTTCAAGTGATAAGAGCTGGAGGAAACAAGAATCTAGAAGGACCAATACCACATGAAATTGGAAACTGTTCCAATTTGATCATGTTGGGTTTAGCAGAAACAAGCATCTCTGGTTTCATTCCACCAACTATTGGACTACTGAAAAAGCTTGAAACTTTAGCCATTTACACTTCACTCCTCTCTGGCCAAATTCCTCCTGAAATTGGTGACTGCACAAATCTTCAAAACATTTACCTTTATGAAAACTCACTCACAGGTTCCATTCCAACCAAATTAGGAAACCTTAACAATCTCAAAAACCTACTACTCTGGCAGAACAGCTTAGTTGGCACAATTCCACCAGAGATTGGGAACTGCTACCAACTATCAGTCATCGACGCGTCGATGAATTCAATAACAGGAAGCATTCCCAAAACCTTTGGGAATTTAACTTTGCTACAAGAACTACAATTGAGTGTGAACCAAATCTCTGGTGAGATTCCTGCAGAATTGGGAAACTGTCAACAACTGACTCACGTGGAGATTGATAACAACCTTATAACCGGTACAATACCTTCCGAATTAGGAAACCTTGGGAATCTAACATTGTTGTTTTTGTGGCATAATAGGTTACAAGGTAATATACCTTCAACTCTTTCCAATTGTCAATACCTTGAAGCCATTGATCTGTCCCAGAATTTGTTAACTGGTCCCATACCAAAGGGTATATTCCAGCTTCAGAATCTCAACAAGCTTTTGCTTCTCTCTAACAATCTCTCTGGTAAAATTCCCTCTCAGATTGGGAATTGTTCGTCTCTTATTCGCTTCAGAGCTAATAATAACAACATTACCGGTATCATTCCTTCTCAGATTGGTAATCTCAAGAATTTGAATTTCCTTGACCTAGGGAGTAATAGGATCTCTGGTGTTATCCCGGAGGAAATCTCCGGCTGCCGGAATCTTACTTTCTTGGATTTGCATGCAAATTCCATTGCCGGAATCTTGCCGGAAAGTTTAAGCAAGCTTGTTTCACTTCAATTTCTTGATTTCTCCGATAACATGATCGAAGGCACATTGAATCCATCTCTCGGCTCGCTCGCCGCTCTTACAAAACTTGTTCTCCGGCAAAATCGAATCTCCGGTGAAATCCCGATGAAACTCGGTTCATGTGAGAAGCTACAGTTACTTGATCTCAGCAGCAATCAACTCTCCGGTGAAATCCCTAGCACCATCGGAGACATTCCGGCGCTAGAAATAGCTTTAAATCTCAGCACAAACCAACTCTCCGGCGAGATTCCACACGAGTTTTCAAGCTTAACAAAACTCGGAATTCTTGATCTATCTCACAATATTCTCACCGGAAACCTAGATTATCTCGCCGGTTTAGAAAATCTCGTGGTCCTCAATATCTCAAACAACAAATTCTCCGGTCACGTTCCGAATACACCGTTCTTCGAGAAGCTTCCAATGAACGTTCTCTCAGGGAACCCTTCTCTATGTTTCTCCGGCAACAATTGCACCGGTGAAGGTGGTGGAAAATCAGGTCGCCGAGCGAGGGAAGCGCGTGTGGTGATGATTGTTCTTCTTTGCGTCGCGTGCGTTTTACTCATGGCGGCGTTATACGTCGTCGTCGCAGCAAAACGACGCGGGGACGAAGAAAACGACGTGGAGCGAAAAGATAGCGACGGTGAAATGGTCCCACCTTGGGAAGTGACACTGTACCAGAAACTCGATCTGTCAATCTCCGACGTGGCAAAATGTATCTCTGCTAACAACATAATCGGACACGGTCGATCCGGAGTCGTTTATAAAGTTACCATGCCCACAGGATTAACCATCGCAGTTAAAAAATTCCGGCTGTCGGATAAATTCTCAGCGTCATCATTCTCATCAGAGATTGCGACACTGGCAAGAATCCGACACCGGAATATTGTTCGGTTATTGGGCTGGGGTGCTAACAGGAGGGCAAAGTTACTGTTTTATGATTATTTACCGAACGGTAATTTGGATGCTATGTTACATGAGGGGTGTACAGGATTAGCTGTGGAGTGGGAGACACGGCTTAAGATAGCAATTGGTGTTGCTGAAGGGTTGGCTTATTTGCATCATGATTGTGTTCCTGCTATCTTGCACCGGGATGTTAAGGCGCAGAATATTTTGTTAGATGATAGATATGAAGCTTGTTTGGCTGATTTTGGATTTGCTCGTTTCGTTGAAGAACAACCGCATGCTTCCTTTTCTGTTAATCCTCAGTTCGCGGGTTCTTACGGCTACATTGCTCCTGAGTATGCCTGTATGCTTAAAATAACTGAGAAGAGTGATGTATACAGCTTTGGTGTGGTCCTACTAGAGATAATAACAGGAAAAAGACCAGTTGATCCATCATTCCCGGATGGAATTCATGTTATTCAATGGGTTAGGGAGCATTTAAAGAGCAAGAAGGACCCAATTGAGGTTCTTGATTCCAAGCTTCAAGGCCATCCAGACACACAAATACAAGAGATGTTACAAGCACTTGGTATCTCTTTATTGTGTACAAGTAATCGCGCTGACGATCGGCCCACCATGAAAGATGTTGCTGCATTATTGAGAGAAATTCGACATGATCCTACATCAGGTGCTGAGCCCCACAAGCCTAAAAGATCAGAAGCTTCGTCGTATTCTTCGTCATCTGTGACCCCAGCTCAGTTGTTGCTTCTACAGTCAAATTCATATTCCTCATCCATTGCTTATTCTTCTTCCTCAACCGCAGCAGCTTACCACTCACCAAGGAACCAATCATGA 3336 0.4296 MPKNPWTLFFLFIFLLLPHHFFLSIAVNTQGEALLSWKRTLNGSLEILNNWDPIEDTPCSWFGVSCNMKNEVVQLDLRYVDLLGKLPTNFTSLFSLTSLILTGTNLTGSIPKEIANLFELSYLDLSDNALSGEIPSELCYLPKLEELHLNSNELVGSIPIAVGNLTKLTKLILYDNQLSGKIPNTIGNMKNLQVIRAGGNKNLEGPIPHEIGNCSNLIMLGLAETSISGFIPPTIGLLKKLETLAIYTSLLSGQIPPEIGDCTNLQNIYLYENSLTGSIPTKLGNLNNLKNLLLWQNSLVGTIPPEIGNCYQLSVIDASMNSITGSIPKTFGNLTLLQELQLSVNQISGEIPAELGNCQQLTHVEIDNNLITGTIPSELGNLGNLTLLFLWHNRLQGNIPSTLSNCQYLEAIDLSQNLLTGPIPKGIFQLQNLNKLLLLSNNLSGKIPSQIGNCSSLIRFRANNNNITGIIPSQIGNLKNLNFLDLGSNRISGVIPEEISGCRNLTFLDLHANSIAGILPESLSKLVSLQFLDFSDNMIEGTLNPSLGSLAALTKLVLRQNRISGEIPMKLGSCEKLQLLDLSSNQLSGEIPSTIGDIPALEIALNLSTNQLSGEIPHEFSSLTKLGILDLSHNILTGNLDYLAGLENLVVLNISNNKFSGHVPNTPFFEKLPMNVLSGNPSLCFSGNNCTGEGGGKSGRRAREARVVMIVLLCVACVLLMAALYVVVAAKRRGDEENDVERKDSDGEMVPPWEVTLYQKLDLSISDVAKCISANNIIGHGRSGVVYKVTMPTGLTIAVKKFRLSDKFSASSFSSEIATLARIRHRNIVRLLGWGANRRAKLLFYDYLPNGNLDAMLHEGCTGLAVEWETRLKIAIGVAEGLAYLHHDCVPAILHRDVKAQNILLDDRYEACLADFGFARFVEEQPHASFSVNPQFAGSYGYIAPEYACMLKITEKSDVYSFGVVLLEIITGKRPVDPSFPDGIHVIQWVREHLKSKKDPIEVLDSKLQGHPDTQIQEMLQALGISLLCTSNRADDRPTMKDVAALLREIRHDPTSGAEPHKPKRSEASSYSSSSVTPAQLLLLQSNSYSSSIAYSSSSTAAAYHSPRNQS* 1112
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Mal5g4082 1111 PRINTS Leucine-rich repeat signature 623 636 - -
Mal5g4082 1111 PRINTS Leucine-rich repeat signature 577 590 - -
Mal5g4082 1111 Pfam Leucine rich repeat 463 515 IPR001611 GO:0005515
Mal5g4082 1111 PANTHER OS01G0170300 PROTEIN 6 1068 - -
Mal5g4082 1111 SMART serkin_6 772 1047 IPR000719 GO:0004672|GO:0005524|GO:0006468
Mal5g4082 1111 PANTHER LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE FAMILY PROTEIN-RELATED 6 1068 - -
Mal5g4082 1111 Gene3D Ribonuclease Inhibitor 435 691 IPR032675 -
Mal5g4082 1111 ProSiteProfiles Protein kinase domain profile. 772 1055 IPR000719 GO:0004672|GO:0005524|GO:0006468
Mal5g4082 1111 Gene3D Phosphorylase Kinase; domain 1 749 847 - -
Mal5g4082 1111 MobiDBLite consensus disorder prediction 1051 1074 - -
Mal5g4082 1111 Pfam Leucine rich repeat N-terminal domain 28 67 IPR013210 -
Mal5g4082 1111 ProSitePatterns Protein kinases ATP-binding region signature. 778 801 IPR017441 GO:0005524
Mal5g4082 1111 MobiDBLite consensus disorder prediction 1051 1066 - -
Mal5g4082 1111 SUPERFAMILY Protein kinase-like (PK-like) 759 1047 IPR011009 -
Mal5g4082 1111 SUPERFAMILY RNI-like 75 396 - -
Mal5g4082 1111 SMART LRR_sd22_2 117 149 - -
Mal5g4082 1111 SMART LRR_sd22_2 478 501 - -
Mal5g4082 1111 SMART LRR_sd22_2 526 552 - -
Mal5g4082 1111 SMART LRR_sd22_2 262 288 - -
Mal5g4082 1111 SMART LRR_sd22_2 165 194 - -
Mal5g4082 1111 SMART LRR_sd22_2 623 648 - -
Mal5g4082 1111 Gene3D Ribonuclease Inhibitor 219 326 IPR032675 -
Mal5g4082 1111 Gene3D Ribonuclease Inhibitor 327 427 IPR032675 -
Mal5g4082 1111 Gene3D Transferase(Phosphotransferase) domain 1 848 1071 - -
Mal5g4082 1111 SUPERFAMILY L domain-like 375 685 - -
Mal5g4082 1111 ProSitePatterns Serine/Threonine protein kinases active-site signature. 893 905 IPR008271 GO:0004672|GO:0006468
Mal5g4082 1111 Pfam Protein kinase domain 775 1043 IPR000719 GO:0004672|GO:0005524|GO:0006468
Mal5g4082 1111 SMART LRR_typ_2 382 406 IPR003591 -
Mal5g4082 1111 SMART LRR_typ_2 526 550 IPR003591 -
Mal5g4082 1111 SMART LRR_typ_2 478 502 IPR003591 -
Mal5g4082 1111 SMART LRR_typ_2 165 189 IPR003591 -
Mal5g4082 1111 SMART LRR_typ_2 503 525 IPR003591 -
Mal5g4082 1111 SMART LRR_typ_2 286 310 IPR003591 -
Mal5g4082 1111 SMART LRR_typ_2 334 358 IPR003591 -
Mal5g4082 1111 SMART LRR_typ_2 117 141 IPR003591 -
Mal5g4082 1111 SMART LRR_typ_2 646 679 IPR003591 -
Mal5g4082 1111 Gene3D Ribonuclease Inhibitor 29 139 IPR032675 -
Mal5g4082 1111 Gene3D Ribonuclease Inhibitor 140 218 IPR032675 -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Mal5g4082 Mal-Chr5 111159357 111163449 Transposed
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Mal5g4082 25 1100 Receptor kinase-like Gene Family AT5G56040 53.740 0.0 1122
       

Transcription factors information

Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-XI-1 Mal5g4082 Pkinase 1.6e-41 CL0016
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Mal5g4082 - - gmx:100778064 1712.2
       

Event-related genes

Select Gene_1 Chr_1 Start_1 End_1 Gene_2 Chr_2 Start_2 End_2 Event_name
Mal5g4082 5 111159357 111163449 Mal5g4082 5 111159357 111163449 ECH